Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.4.7.1159
Reference22 articles.
1. Cancer Statistics, 2004
2. Recurrent Ovarian Cancer: Evidence-Based Treatment
3. CA-125: an evolving role in the management of ovarian cancer.
4. Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial
5. Effect of Dose on Immune Response in Patients Vaccinated With an HER-2/neu Intracellular Domain Protein—Based Vaccine
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transportation of mAb Dosing Solution in Intravenous Bag: Impact of Manual, Vehicle, and Pneumatic Tube System Transportation Methods on Product Quality;Molecular Pharmaceutics;2023-11-14
2. Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis;Current Chemical Biology;2021-04-27
3. Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction;Journal of Industrial and Engineering Chemistry;2021-02
4. Ovarian Cancer Targeted Theranostics;Frontiers in Oncology;2020-01-21
5. Overview of CD24 as a new molecular marker in ovarian cancer;Journal of Cellular Physiology;2018-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3